SECY-18-0034, SRM-M180503: Affirmation Session, SECY-18-0027: Tennessee Valley Authority (Clinch River Nuclear Site Early Site Permit Application, Docket No 52-047-ESP SECY-18-0034: Northwest Medical Isotopes, LLC (Mrpf), Docket No. 50-609-CP, Mandat

From kanterella
(Redirected from SECY-18-0034)
Jump to navigation Jump to search
SRM-M180503: Affirmation Session, SECY-18-0027: Tennessee Valley Authority (Clinch River Nuclear Site Early Site Permit Application, Docket No 52-047-ESP SECY-18-0034: Northwest Medical Isotopes, LLC (Mrpf), Docket No. 50-609-CP, Mandatory
ML18123A474
Person / Time
Issue date: 05/03/2018
From: Annette Vietti-Cook
NRC/SECY
To:
References
Download: ML18123A474 (2)


Text

UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 May 3, 2018 IN RESPONSE, PLEASE REFER TO: M180503 MEMORANDUM FOR: Andrew P. Averbach, Acting Director Office of Commission Appellate Adjudication FROM: Annette L. Vietti-Cook, Secretary /RA/

SUBJECT:

STAFF REQUIREMENTS - AFFIRMATION SESSION, 1:00 P.M.,

THURSDAY, MAY 3, 2018, COMMISSIONERS' CONFERENCE ROOM, ONE WHITE FLINT NORTH, ROCKVILLE, MARYLAND (OPEN TO PUBLIC ATTENDANCE)

I. SECY-18-0027 -TENNESSEE VALLEY AUTHORITY (CLINCH RIVER NUCLEAR SITE EARLY SITE PERMIT APPLICATION), DOCKET NO. 52-047-ESP, APPLICANTS APPEAL OF LBP-17-8 The Commission approved a Memorandum and Order addressing Tennessee Valley Authoritys appeal of the Atomic Safety and Licensing Boards decision in LBP-17-8, in which the Board granted a hearing request jointly filed by the Southern Alliance for Clean Energy and the Tennessee Environmental Council and admitted two contentions. The Memorandum and Order affirms in part and reverses in part the Boards decision.

(Subsequently, on May 3, 2018, the Secretary signed the Memorandum and Order.)

II. SECY-18-0034 - NORTHWEST MEDICAL ISOTOPES, LLC (MEDICAL RADIOISOTOPE PRODUCTION FACILITY), DOCKET NO. 50-609-CP, MANDATORY HEARING DECISION The Commission approved a Memorandum and Order addressing the required findings and the issues discussed at the uncontested hearing on January 23, 2018, concerning the application of Northwest Medical Isotopes, LLC, to construct a medical radioisotope production facility in Columbia, Missouri. The Memorandum and Order authorizes issuance of the construction permit, contingent upon inclusion of the revised permit condition described in Section II.B.

(Subsequently, on May 3, 2018, the Secretary signed the Memorandum and Order.)

cc: Chairman Svinicki Commissioner Baran Commissioner Burns EDO

OGC CFO OCAA OCA OIG OPA ODs, RAs, ACRS, ASLBP (via E-Mail)

PDR